Frances M. Boyle

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos et al. · The Lancet Oncology · 2019 · 464 citations

Breast Oncology, Oncology, Pharmacology +8

Beating the barriers: recruitment of people with intellectual disability to participate in research

Nicholas Lennox, Michael Taylor, Therese Rey‐Conde et al. · Journal of Intellectual Disability Research · 2005 · 226 citations

Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma

Frances M. Boyle, Susan Pendlebury, David Bell · International Journal of Radiation Oncology*Biology*Physics · 1995 · 179 citations

Merkel Cell, Medicine, Surgical Pathology +9

The mental health impact of stillbirth, neonatal death or SIDS: Prevalence and patterns of distress among mothers

Frances M. Boyle, John C. Vance, Jake M. Najman et al. · Social Science & Medicine · 1996 · 144 citations

Family Medicine, Perinatal Health, Psychiatry +13